These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32008432)

  • 21. Current Status and Future Perspectives of Renal Denervation.
    Choi KH; Choi SH
    Korean Circ J; 2021 Sep; 51(9):717-732. PubMed ID: 34227270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of renal denervation for Chinese patients with resistant hypertension using a microirrigated catheter: study design and protocol for a prospective multicentre randomised controlled trial.
    Liu Z; Shen L; Huang W; Zhao X; Fang W; Wang C; Yin Z; Wang J; Fu G; Liu X; Jiang J; Zhang Z; Li J; Lu Y; Ge J
    BMJ Open; 2017 Sep; 7(9):e015672. PubMed ID: 28864691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ReferencesEfficiency and safety of renal denervation via cryoablation (Cryo-RDN) in Chinese patients with uncontrolled hypertension: study protocol for a randomized controlled trial.
    Chen H; Ji M; Zhang Y; Xu Y; Qiao L; Shen L; Ge J
    Trials; 2019 Nov; 20(1):653. PubMed ID: 31779672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
    Böhm M; Tsioufis K; Kandzari DE; Kario K; Weber MA; Schmieder RE; Townsend RR; Kulenthiran S; Ukena C; Pocock S; Ewen S; Weil J; Fahy M; Mahfoud F
    J Am Coll Cardiol; 2021 Sep; 78(10):1028-1038. PubMed ID: 34474735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study.
    Vink EE; Goldschmeding R; Vink A; Weggemans C; Bleijs RL; Blankestijn PJ
    Nephrol Dial Transplant; 2014 Aug; 29(8):1608-10. PubMed ID: 24875664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal denervation therapy for resistant hypertension: a clinical update.
    Ram CV; Kumar AS
    J Hum Hypertens; 2014 Dec; 28(12):699-704. PubMed ID: 24599151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.
    Jacobs L; Persu A; Huang QF; Lengelé JP; Thijs L; Hammer F; Yang WY; Zhang ZY; Renkin J; Sinnaeve P; Wei FF; Pasquet A; Fadl Elmula FEM; Carlier M; Elvan A; Wunder C; Kjeldsen SE; Toennes SW; Janssens S; Verhamme P; Staessen JA;
    Blood Press; 2017 Dec; 26(6):321-331. PubMed ID: 28489464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves.
    Katsurada K; Kario K
    Hypertens Res; 2023 Jun; 46(6):1462-1470. PubMed ID: 36991064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
    Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
    Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.
    Mountfort K; Mahfoud F; Schmieder R; Davies J; Kandzari DE; Weil J; Whitbourn R
    Interv Cardiol; 2013 Aug; 8(2):118-123. PubMed ID: 29588763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M
    Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial.
    Jin Y; Jacobs L; Baelen M; Thijs L; Renkin J; Hammer F; Kefer J; Petit T; Verhamme P; Janssens S; Sinnaeve P; Lengelé JP; Persu A; Staessen JA;
    Blood Press; 2014 Jun; 23(3):138-46. PubMed ID: 24742341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan).
    Lee CK; Wang TD; Lee YH; Fahy M; Lee CH; Sung SH; Kao HL; Wu YW; Lin TH
    Acta Cardiol Sin; 2019 Nov; 35(6):618-626. PubMed ID: 31879514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.